Publication | Closed Access

An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancer

MedicineInterest TrialClinical TrialsEconomic AnalysisPharmacotherapyRandomized TrialCancer TreatmentDrug TrialOncologyRadiation OncologyLung CancerHealth Sciences